Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Symbiome offers skincare as nature intended solution which is scientifically and intentionally formulated using ancestral ingredients.
Arkuda Therapeutics is a pharmaceutical company.
Pioneering needle-free disease monitoring
A biotechnology company developing RNA technologies to shape the future of gene therapy
Telo Therapeutics is a novel precision medicine approach to reverse cancer cell immortality.
Vedere Bio is developing gene therapy products to restore functional vision to patients who have suffered vision loss.
Epiodyne is a Provider of Biotechnology Research.
Avexegen Therapeutics is a biotechnology company developing therapies for gastrointestinal disorders.
Cell Design Labs is a biotherapeutics company
Pionyr Immunotherapeutics is a developer of cancer immunotherapies designed to target the tumor microenvironment.
Tangible Science is a developer of contact lenses designed to reduce lens discomfort in dry eye diseases.
Comet Therapeutics is a developer of therapies designed to treat orphan neurological disorders.
SYMIC Biomedical operates in the healthcare industry focusing on biotechnology business.
Photoswitch Biosciences is creating new tools for the next generation of questions in excitable membrane biology.
Mitokinin is operates in the healthcare industry focusing on biotechnology business.
ViewPoint Therapeutics is a developer of crystallin stabilizers intended to prevent and treat cataracts and presbyopia.
Mission BioCapital has invested in 64 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Mission BioCapital's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Wellness. The firm invests across 13 different industry categories.
Among tracked funding rounds, Pionyr Immunotherapeutics received $275.0M in a Corporate Round round. Mission BioCapital's total known invested capital is $3.1B.
Mission BioCapital's average investment size is $55.6M across its portfolio of 64 companies.
Recent Mission BioCapital portfolio additions include Symbiome, Arkuda Therapeutics, GraphWear Technologies, Shape Therapeutics, Telo Therapeutics. These companies were founded in 2020 or later.